Caraglia M - Search Results

1

Target-based agents in neoadjuvant treatment of liver metastases from colorectal cancer: secret weapons in anti-cancer war?

Marra M, Giudice A, Arra C, Vitale G, Castiglioni S, Nasti G, Lombardi A, Ottaiano A, Facchini G, Iaffaioli RV, Abbruzzese A, Caraglia M. Marra M, et al. Among authors: caraglia m. Cancer Biol Ther. 2009 Sep;8(18):1709-18. doi: 10.4161/cbt.8.18.9600. Epub 2009 Sep 24. Cancer Biol Ther. 2009. PMID: 19729997 Free article. Review.

2

Structural organization of the human eukaryotic initiation factor 5A precursor and its site-directed variant Lys50-->Arg.

Stiuso P, Colonna G, Ragone R, Caraglia M, Hershey JW, Beninati S, Abbruzzese A. Stiuso P, et al. Among authors: caraglia m. Amino Acids. 1999;16(1):91-106. doi: 10.1007/BF01318888. Amino Acids. 1999. PMID: 10078337

3

Up-regulated EGF receptors undergo to rapid internalization and ubiquitin-dependent degradation in human cancer cells exposed to 8-Cl-cAMP.

Caraglia M, Di Gennaro E, Barbarulo D, Marra M, Tagliaferri P, Abbruzzese A, Budillon A. Caraglia M, et al. FEBS Lett. 1999 Mar 26;447(2-3):203-8. doi: 10.1016/s0014-5793(99)00292-6. FEBS Lett. 1999. PMID: 10214946 Free article.

4

8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.

Budillon A, Di Gennaro E, Caraglia M, Barbarulo D, Abbruzzese A, Tagliaferri P. Budillon A, et al. Among authors: caraglia m. Br J Cancer. 1999 Dec;81(7):1134-41. doi: 10.1038/sj.bjc.6690820. Br J Cancer. 1999. PMID: 10584873 Free PMC article.

5

Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma.

Vitale G, Tagliaferri P, Caraglia M, Rampone E, Ciccarelli A, Bianco AR, Abbruzzese A, Lupoli G. Vitale G, et al. Among authors: caraglia m. J Clin Endocrinol Metab. 2000 Mar;85(3):983-8. doi: 10.1210/jcem.85.3.6435. J Clin Endocrinol Metab. 2000. PMID: 10720027 Clinical Trial.

6

Post-translational modifications of eukaryotic initiation factor-5A (eIF-5A) as a new target for anti-cancer therapy.

Caraglia M, Tagliaferri P, Budillon A, Abbruzzese A. Caraglia M, et al. Adv Exp Med Biol. 1999;472:187-98. doi: 10.1007/978-1-4757-3230-6_16. Adv Exp Med Biol. 1999. PMID: 10736626

7

Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation.

Caraglia M, Budillon A, Vitale G, Lupoli G, Tagliaferri P, Abbruzzese A. Caraglia M, et al. Eur J Biochem. 2000 Jul;267(13):3919-36. doi: 10.1046/j.1432-1327.2000.01465.x. Eur J Biochem. 2000. PMID: 10866791 Free article. Review.

8

Evaluation of the efficacy of potential antineoplastic drugs on tumour metastasis by a computer-assisted image analysis.

Lentini A, Autuori F, Mattioli P, Caraglia M, Abbruzzese A, Beninati S. Lentini A, et al. Among authors: caraglia m. Eur J Cancer. 2000 Aug;36(12):1572-7. doi: 10.1016/s0959-8049(00)00147-7. Eur J Cancer. 2000. PMID: 10930806

9

Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice.

Lentini A, Vidal-Vanaclocha F, Facchiano F, Caraglia M, Abbruzzese A, Beninati S. Lentini A, et al. Among authors: caraglia m. Melanoma Res. 2000 Oct;10(5):435-43. doi: 10.1097/00008390-200010000-00005. Melanoma Res. 2000. PMID: 11095404

10

The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis.

Caraglia M, Marra M, Giuberti G, D'Alessandro AM, Budillon A, del Prete S, Lentini A, Beninati S, Abbruzzese A. Caraglia M, et al. Amino Acids. 2001;20(2):91-104. doi: 10.1007/s007260170050. Amino Acids. 2001. PMID: 11332455 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

543 results

Search Page

Filters